Wednesday, May 14th
1:00PM – 2:00PM ET
Virtual Webinar
The Lung-MAP Accrual Enhancement Committee (AEC) is hosting an upcoming public webinar titled, Advocating, Accelerating, and Amplifying Lung Cancer Discovery. The webinar will feature experts from the current Lung-MAP clinical trial to discuss recent trial updates, challenges to the traditional clinical trial landscape that Lung-MAP is working to overcome, and opportunities for patient engagement in the process. The event will feature a panel discussion among lung cancer advocates with their perspectives on these topics.
Lung-MAP is a cancer clinical trial designed to quickly and efficiently test new treatments for advanced non-small cell lung cancers – which make up about 85 percent of all lung cancer diagnoses in the United States. Lung-MAP is offered at hospitals and clinics country wide, making it easier for patients to participate and get access to investigational treatments to fight their lung cancer.
Click the link above to register.
Agenda
1:00 PM | Welcome Remarks
- Ryan Hohman, Friends of Cancer Research
1:05 PM | Lung-MAP Today: Accelerating and Amplifying Lung Cancer Discovery
Overview of Lung-MAP 3.0 and Progress on Lung-MAP Studies
- Moderator: Jennifer Newsome, Foundation for the National Institutes of Health
- Dr. Karen Reckamp, Cedars-Sinai Cancer; Chair, Lung-MAP Study
1:15 PM | Lung-MAP Perspectives
Update on Current Study: S1900K
- Moderator: Judy Johnson, Research Patient Advocate
- Dr. Paul Paik, Memorial Sloan Kettering Cancer Center; Chair, S1900K Study
Lung-MAP Opportunities and Challenges from a Clinician’s Perspective
- Moderator: Judy Johnson, Research Patient Advocate
- Dr. Bryan Faller, Missouri Baptist Medical Center
1:30 PM | Panel: Amplifying Patient Voices
Advocates Panel Discussion
- Moderator: Ryan Hohman, Friends of Cancer Research
- Andrea Ferris, LUNGevity
- Marcia Horn, MET Crusaders and International Cancer Advocacy Network
- Kim Norris, Lung Cancer Foundation of America
1:58 PM | Closing Remarks
- Frank DeSanto, SWOG Cancer Research Network
Lung-MAP is a groundbreaking public-private partnership that includes the NCI and its National Clinical Trials Network (NCTN) including SWOG Cancer Research Network, Friends of Cancer Research (Friends), the Foundation for the National Institutes of Health (FNIH), Foundation Medicine, pharmaceutical companies which provided their drugs for the study, and several lung cancer advocacy organizations.
